RESEARCH ARTICLE Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa Liyun Zhang1, Conan Chen1†, Jie Fu2, Brendan Lilley1, Cynthia Berlinicke1, Baranda Hansen1‡, Ding Ding3, Guohua Wang1§, Tao Wang2,4,5, Daniel Shou2, Ying Ye2, Timothy Mulligan1, Kevin Emmerich1,6, Meera T Saxena1, Kelsi R Hall7#, Abigail V Sharrock3,7, Carlene Brandon8, Hyejin Park9, Tae-In Kam9,10, Valina L Dawson9,10,11,12, Ted M Dawson9,10,11,12, Joong Sup Shim13, Justin Hanes1,2, Hongkai Ji3, Jun O Liu11,14, Jiang Qian1, David F Ackerley7, Baerbel Rohrer8, Donald J Zack1,2,6,12,15, Jeff S Mumm1,2,6,12* 1Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States; 2The Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University, Baltimore, United States; 3Department of Biostatistics, Johns Hopkins University, Baltimore, United States; 4School of Chemistry, Xuzhou College of Industrial Technology, Xuzhou, China; 5College of Light Industry and Food Engineering, Nanjing Forestry University, Nanjing, China; 6Department of 7 *For correspondence: Genetic Medicine, Johns Hopkins University, Baltimore, United States; School of
[email protected] Biological Sciences, Victoria University of Wellington, Wellington, New Zealand; 8 Present address: †University of Department of Ophthalmology, Medical University of South Carolina, Charleston, 9 Colorado Anschutz Medical United States; Department of Neurology, Johns Hopkins University, Baltimore, Campus, Aurora, United